BioCentury
ARTICLE | Company News

Vaxart, Department of Health and Human Services infectious news

November 9, 2015 8:00 AM UTC

HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded Vaxart a two-year contract worth up to $14 million to support the development of oral recombinant influenza vaccines. The f...